<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This report summarizes the experience with 25 patients who received a second marrow transplant </plain></SENT>
<SENT sid="1" pm="."><plain>The marrow donor for the first transplant was an identical twin in four cases and a sibling matched at the major histocompatibility complex in 21 instances </plain></SENT>
<SENT sid="2" pm="."><plain>The donor for the second transplant was the same as the first except for three patients whose second donor was another matched sibling </plain></SENT>
<SENT sid="3" pm="."><plain>Nine patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> rejected their first graft </plain></SENT>
<SENT sid="4" pm="."><plain>Four of these patients were prepared for the second graft with a regimen of procarbazine and antithymocyte globulin (ATG) followed by <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> or total body irradiation and were successfully regrafted </plain></SENT>
<SENT sid="5" pm="."><plain>One rejected the second graft, two died of <z:mpath ids='MPATH_681'>septicemia</z:mpath> and one is alive and well 10 months after the second graft </plain></SENT>
<SENT sid="6" pm="."><plain>Twelve patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> had a recurrence of disease after the first transplant </plain></SENT>
<SENT sid="7" pm="."><plain>Despite preparation for the second graft with a variety of intensive chemotherapeutic regimens, the five patients who did not succumb to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> showed an early recurrence of disease </plain></SENT>
<SENT sid="8" pm="."><plain>Four patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> had a failure of the first graft for unknown reasons, possibly related to the administration of ATG or <z:chebi fb="0" ids="44185">methotrexate</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>One patient prepared for the second graft with procarbazine and ATG showed evidence of engraftment but died of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Two out of three patients given no additional preparation were successfully grafted </plain></SENT>
<SENT sid="11" pm="."><plain>One died of recurrent central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0001909'>leukemia</z:hpo> after 18 months and one is alive and well 26 months after the second graft </plain></SENT>
</text></document>